M&A Deal Summary

Ally Biotech Acquires Chill Pill

On March 20, 2023, Ally Biotech acquired life science company Chill Pill

Acquisition Highlights
  • This is Ally Biotech’s 1st transaction in the Life Science sector.
  • This is Ally Biotech’s 1st transaction in the United States.
  • This is Ally Biotech’s 1st transaction in Arizona.

M&A Deal Summary

Date 2023-03-20
Target Chill Pill
Sector Life Science
Buyer(s) Ally Biotech
Deal Type Add-on Acquisition

Target

Chill Pill

Mesa, Arizona, United States
Chill Pill is an extensive line of soft, easy-to-swallow soft gel caps distributed in nearly 40 licensed Arizona dispensaries. Its soft gel cap line includes Day Caps – a sativa-dominant formula, Anytime Caps – a formulation that combines sativa and indica, Night Caps – an indica dominant formula, Anytime Caps + CBD – a 1:1 blend of THC and CBD, and THC-A – Non-intoxicating symptom relief with no psychoactive effects. Chill Pill was formed in 2018 and is based in Mesa, Arizona.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ally Biotech

Payson, Arizona, United States

Category Company
Sector Life Science
DESCRIPTION

Ally Biotech offers highly bioavailable products to leading manufacturers and dispensaries of cannabis products. The Company’s Lipofusion delivery technology combines nanotechnology and liposomal science to speed product differentiation and innovation. It also offers product development services, and manufacturing-ready, water-soluble Lipofusion THC that can be utilized as a raw ingredient in powder or liquid form in a variety of products. All of the company’s products undergo rigorous testing for purity, potency, safety, and efficacy at third-party laboratories. Ally Biotech is based in Payson, Arizona.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Arizona) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1